Related references
Note: Only part of the references are listed.Prolonged Beneficial Effect of Brief Erythropoietin Peptide JM4 Therapy on Chronic Relapsing EAE
Deeya Gaindh et al.
NEUROTHERAPEUTICS (2021)
Targeting the brain lesions using peptides: A review focused on the possibility of targeted drug delivery to multiple sclerosis lesions
Atefeh Rayatpour et al.
PHARMACOLOGICAL RESEARCH (2021)
A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future
Mehrdad Gholamzad et al.
INFLAMMATION RESEARCH (2019)
Developing therapeutic strategies to promote myelin repair in multiple sclerosis
Laura E. Baldassari et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
Protective Effect of PBCA Nanoparticles Loaded with Thymulin Against the Relapsing-Remitting Form of Experimental Autoimmune Encephalomyelitis in Mice
Sergey M. Lunin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Immune response in the relapsing-remitting experimental autoimmune encephalomyelitis in mice: The role of the NF-κB signaling pathway
S. M. Lunin et al.
CELLULAR IMMUNOLOGY (2019)
Targeting inflammatory components in neuropathic pain: The analgesic effect of thymulin related peptide
Bared Safieh-Garabedian et al.
NEUROSCIENCE LETTERS (2019)
Pulsed immune reconstitution therapy in multiple sclerosis
Per Soelberg Sorensen et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis
Barbara Willekens et al.
CNS DRUGS (2018)
Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain
Jessica L. Fletcher et al.
JOURNAL OF NEUROSCIENCE (2018)
A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87-99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis
Mary Emmanouil et al.
MOLECULES (2018)
Thymulin, free or bound to PBCA nanoparticles, protects mice against chronic septic inflammation
Elena G. Novoselova et al.
PLOS ONE (2018)
Role of nuclear factor κB in multiple sclerosis and experimental autoimmune encephalomyelitis
Yuan Yue et al.
NEURAL REGENERATION RESEARCH (2018)
[Tc-99m][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of alpha v beta(3) Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies
Cristina Bolzati et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Immune-cell crosstalk in multiple sclerosis
Richard M. Ransohoff
NATURE (2018)
ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 x Ob1)F1 Mice by Induction of IL-10-Secreting iTregs
Adriano Luis Soares De Souza et al.
NEUROLOGY AND THERAPY (2018)
Chemical Modification for Proteolytic Stabilization of the Selective αvβ3 Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma Cells
Daniela Comegna et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Achievements and obstacles of remyelinating therapies in multiple sclerosis
Martin Stangel et al.
NATURE REVIEWS NEUROLOGY (2017)
Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis
Evilin Naname Komegae et al.
PLOS ONE (2017)
Beneficial Effect of Erythropoietin Short Peptide on Acute Traumatic Brain Injury
Bo Wang et al.
NEUROTHERAPEUTICS (2016)
Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis
Kathrin Thell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Inflammatory Th17 Cells Express Integrin αvβ3 for Pathogenic Function
Fang Du et al.
Cell Reports (2016)
Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96) MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis
George Deraos et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
A basic overview of multiple sclerosis immunopathology
N. Grigoriadis et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Modulation of inflammatory response in mice with severe autoimmune disease by thymic peptide thymulin and an inhibitor of NF-kappaB signalling
S. M. Lunin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants
Veronica De Rosa et al.
NATURE IMMUNOLOGY (2015)
A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection
RuiRong Yuan et al.
NEUROTHERAPEUTICS (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
Heather B. Streeter et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Regulatory T cell proliferative potential is impaired in human autoimmune disease
Fortunata Carbone et al.
NATURE MEDICINE (2014)
Anti-Inflammatory Effects of IKK Inhibitor XII, Thymulin, and Fat-Soluble Antioxidants in LPS-Treated Mice
E. G. Novoselova et al.
MEDIATORS OF INFLAMMATION (2014)
Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis
Jelle Praet et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis
S. M. Lunin et al.
IMMUNOBIOLOGY (2013)
Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?
A. H. Nuyts et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism
Carsten Gruendemann et al.
PLOS ONE (2013)
Immune modulating peptides for the treatment and suppression of multiple sclerosis
Ahmed H. Badawi et al.
CLINICAL IMMUNOLOGY (2012)
Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm
Helena Batoulis et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2010)
Thymus hormones as prospective anti-inflammatory agents
Sergey M. Lunin et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis?
M. P. Pender
BRAIN (2009)
Epstein-barr virus in multiple sclerosis
Bridget A. Bagert
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2009)
Shifting therapeutic attention in MS to osteopontin, type 1 and type 2 IFN
Lawrence Steinman
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
Yeonseok Chung et al.
IMMUNITY (2009)
Design and Synthesis of a Cyclic Double Mutant Peptide (cyclo(87-99)[A91,A96]MBP87-99) Induces Altered Responses in Mice after Conjugation to Mannan: Implications in the Immunotherapy of Multiple Sclerosis
Maria Katsara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
Hannelore Ehrenreich et al.
STROKE (2009)
Multiple sclerosis: major histocompatibility complexity and antigen presentation
Sreeram V. Ramagopalan et al.
GENOME MEDICINE (2009)
Thymulin, A Thymic Peptide, Prevents the Overproduction of Pro-Inflammatory Cytokines and Heat Shock Protein Hsp70 in Inflammation-Bearing Mice
S. M. Lunin et al.
IMMUNOLOGICAL INVESTIGATIONS (2008)
Dissection of the multiple sclerosis associated DR2 haplotype
Ruth Etzensperger et al.
JOURNAL OF AUTOIMMUNITY (2008)
Increased Osteopontin Expression in Dendritic Cells Amplifies IL-17 Production by CD4+ T Cells in Experimental Autoimmune Encephalomyelitis and in Multiple Sclerosis
Gopal Murugaiyan et al.
JOURNAL OF IMMUNOLOGY (2008)
Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice
Maria Katsara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
May H. Han et al.
NATURE (2008)
Venous thromboembolic events and erythropoiesis-stimulating agents: An update
Mario Dicato
ONCOLOGIST (2008)
Erythropoietin: A Potent Inducer of Peripheral Immuno/Inflammatory Modulation in Autoimmune EAE
RuiRong Yuan et al.
PLOS ONE (2008)
The origin and application of experimental autoimmune encephalomyelitis
Alan G. Baxter
NATURE REVIEWS IMMUNOLOGY (2007)
Efficacy and safety of epoetin alfa in critically ill patients
Howard L. Corwin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease
Ryan A. Adams et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Multiple sclerosis: a complicated picture of autoimmunity
Henry F. McFarland et al.
NATURE IMMUNOLOGY (2007)
Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease
Marc Veldhoen et al.
NATURE IMMUNOLOGY (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Transforming growth factor-β induces development of the TH17 lineage
PR Mangan et al.
NATURE (2006)
Molecular mimicry, bystander activation, or viral persistence: Infections and autoimmune disease
RS Fujinami et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis
MR Lincoln et al.
NATURE GENETICS (2005)
Design and synthesis of a novel potent myelin basic protein epitope 87-99 cyclic analogue: Enhanced stability and biological properties of mimics render them a potentially new class of immunomodulators
J Matsoukas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Antiangiogenic effects of anti-tumor necrosis factor a therapy with infliximab in psoriatic arthritis
JD Cañete et al.
ARTHRITIS AND RHEUMATISM (2004)
Beneficial effect of erythropoietin on experimental allergic encephalomyelitis
WP Li et al.
ANNALS OF NEUROLOGY (2004)
Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study
AY Goedkoop et al.
ARTHRITIS RESEARCH & THERAPY (2004)
The genetic epidemiology of multiple sclerosis
SJ Kenealy et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Blood-brain barrier disruption in multiple sclerosis
A Minagar et al.
MULTIPLE SCLEROSIS JOURNAL (2003)
Diversity and dynamics of the T-cell response to MBP in DR2+ve individuals
G Mazza et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Antagonistic effects of human cyclic MBP87-99 altered peptide ligands in experimental allergic encephalomyelitis and human T-cell proliferation
T Tselios et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice
T Teesalu et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Plant cyclotides: circular, knotted peptide toxins
DJ Craik
TOXICON (2001)
Differential responses of CD45+ve T-cell subsets to MBP in multiple sclerosis
M Ponsford et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Regulation by IFN-β of inducible nitric oxide synthase and interleukin-12/p40 in murine macrophages cultured in the presence of Chlamydia pneumoniae antigens
SY Yao et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72-85
T Tselios et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Share Paper
